Literature DB >> 6416349

The end of clinical freedom.

J R Hampton.   

Abstract

Mesh:

Year:  1983        PMID: 6416349      PMCID: PMC1549736          DOI: 10.1136/bmj.287.6401.1237

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  6 in total

1.  Oral mexiletine in high-risk patients after myocardial infarction.

Authors:  D A Chamberlain; D E Jewitt; D G Julian; R W Campbell; D M Boyle; R G Shanks
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

2.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

Authors:  J L Anderson; H W Marshall; B E Bray; J R Lutz; P R Frederick; F G Yanowitz; F L Datz; S C Klausner; A D Hagan
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

Review 3.  Thrombolytic therapy for acute myocardial infarction: quo vadis? A review of the recent literature.

Authors:  P G Hugenholtz; P Rentrop
Journal:  Eur Heart J       Date:  1982-10       Impact factor: 29.983

4.  Surgery for evolving myocardial infarction.

Authors:  S J Phillips; R H Zeff; C Kongtahworn; J R Skinner; L Iannone; T M Brown; W Wickemeyer; D F Gordon
Journal:  JAMA       Date:  1982-09-17       Impact factor: 56.272

5.  Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.

Authors:  F Khaja; J A Walton; J F Brymer; E Lo; L Osterberger; W W O'Neill; H T Colfer; R Weiss; T Lee; T Kurian; A D Goldberg; B Pitt; S Goldstein
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

6.  Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.

Authors:  R G Wilcox; J M Rowley; J R Hampton; J R Mitchell; J M Roland; D C Banks
Journal:  Lancet       Date:  1980-10-11       Impact factor: 79.321

  6 in total
  37 in total

Review 1.  The medical profession, the public, and the government.

Authors:  Chris Ham; K G M M Alberti
Journal:  BMJ       Date:  2002-04-06

Review 2.  Heart disease, guidelines, regulations, and the law.

Authors:  M C Petch
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

3.  Effective clinical policies in a district general hospital.

Authors:  I J Gordon; E S Jones
Journal:  Health Care Anal       Date:  1998-12

4.  Rules in the clinical setting: pros and cons.

Authors:  J McKie
Journal:  Health Care Anal       Date:  1998-12

5.  The quandary of experimental chemotherapy.

Authors:  B Modan
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

6.  Can rationing of cardiological services be rational?

Authors:  D Chamberlain; R Alderslade
Journal:  Br Heart J       Date:  1990-09

7.  Health economics in primary care in the UK: containment of drug costs.

Authors:  T Walley; R T Edwards
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

8.  Therapeutic fashion and publication bias: the case of anti-arrhythmic drugs in heart attack.

Authors:  John Hampton
Journal:  J R Soc Med       Date:  2015-10       Impact factor: 5.344

9.  Unholy trinity: Stance is worst type of spin.

Authors:  Roger H Jones
Journal:  BMJ       Date:  2007-09-08

10.  Set menus and clinical freedom.

Authors:  T C O'Dowd; A D Wilson
Journal:  BMJ       Date:  1991-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.